Pregled bibliografske jedinice broj: 444631
A Fast Immunoassay for Determination of β-Agonist Residues in plasma
A Fast Immunoassay for Determination of β-Agonist Residues in plasma // Reviews in analytical chemistry, 29 (2010), 1; 39-50 doi:10.1515/REVAC.2010.29.1.39 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 444631 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A Fast Immunoassay for Determination of β-Agonist Residues in plasma
(A Fast Immunoassay for Determination of β-Agonist Residues in Plasma)
Autori
Pleadin, Jelka ; Vulić, Ana ; Stojković, Ranko ; Perši, Nina ; Mitak, Mario ; Zadravec, Manuela
Izvornik
Reviews in analytical chemistry (0793-0135) 29
(2010), 1;
39-50
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
β-agonist residues ; clenbuterol ; salbutamol ; subchronic exposure ; mice ; plasma ; ELISA
Sažetak
Plasma residues of β-agonists during and after oral administration of subchronic anabolic doses of clenbuterol and salbutamol in mice were determined by use of the enzyme-linked immunosorbent assay (ELISA) as analytical method. The reliability of ELISA as a screening method for quantitative determination of clenbuterol and salbutamol plasma residues was tested by assay validation. Plasma usefulness as a matrix in the control of anabolic abuse was tested by determination of clenbuterol and salbutamol plasma residues. On day 28 of anabolic treatment, the peak plasma clenbuterol concentration was 10.75±2.45 ng/mL and 13.57±3.21 ng/mL in white and black mice, respectively, which was a fourfold peak salbutamol concentration (2.50±0.15 ng/mL and 3.66±0.22 ng/mL, respectively). On day 5 of treatment discontinuation, the levels of clenbuterol and salbutamol residues were below the analytical method limit of detection. Results of the method validation showed ELISA to be applicable in quantitative (ng/mL) determination of β-agonist residues in plasma. Study results also indicated plasma to be a suitable matrix in the control of β-agonist abuse ; however, only as a second choice matrix during fattening because of the very short time of the residues being detectable after treatment discontinuation. Therefore, in comparison with other potential matrices (urine and hair), plasma is of a limited value in the control of β-agonist abuse in live animals.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
048-0531854-0467 - Ostaci kemijskih kontaminanata u hrani: Farmakokinetika i toksikologija
098-0982464-2390 - Novi terapijski modaliteti u liječenju malignih bolesti (Stojković, Ranko, MZOS ) ( CroRIS)
Ustanove:
Hrvatski veterinarski institut, Zagreb,
Institut "Ruđer Bošković", Zagreb
Profili:
Manuela Zadravec
(autor)
Ana Vulić
(autor)
Jelka Pleadin
(autor)
Nina Kudumija
(autor)
Mario Mitak
(autor)
Ranko Stojković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus